Prostatis Group’s Schwab Fundamental US Large Company Index ETF FNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Buy
113,083
+4,227
+4% +$120K 0.81% 41
2025
Q4
$2.96M Buy
108,856
+16,977
+18% +$454K 0.71% 39
2025
Q3
$2.42M Buy
91,879
+23,277
+34% +$591K 0.61% 45
2025
Q2
$1.68M Buy
68,602
+5,224
+8% +$122K 0.48% 51
2025
Q1
$1.5M Buy
63,378
+21,131
+50% +$511K 0.47% 45
2024
Q4
$1M Buy
+42,247
New +$1.02M 0.29% 73

Other funds holding FNDX

Prostatis Group's FNDX Position: Q1 2026 in Review

Prostatis Group increased its Schwab Fundamental US Large Company Index ETF (FNDX) stake by 3.9% in Q1 2026, buying an estimated $120K and bringing the position to 113,083 shares worth $3.15M. The position accounts for 0.81% of the portfolio, ranked #41.

Prostatis Group first reported a position in FNDX in Q4 2024 and has held it in 6 quarters since. 776 funds tracked by Wall St. Rank hold FNDX as of Q1 2026.

  • Prostatis Group held 113,083 shares of Schwab Fundamental US Large Company Index ETF worth $3.15M as of Q1 2026.
  • Prostatis Group bought 4,227 Schwab Fundamental US Large Company Index ETF shares in Q1 2026, an estimated $120K.
  • Schwab Fundamental US Large Company Index ETF made up 0.81% of Prostatis Group's portfolio in Q1 2026, its #41 holding.
  • Prostatis Group first reported a position in Schwab Fundamental US Large Company Index ETF in Q4 2024 and has held it in 6 quarters since.
  • 776 funds tracked by Wall St. Rank held Schwab Fundamental US Large Company Index ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.